Search

Search Constraints

You searched for: Author/Creator von Tresckow, Julia

Search Results

1. Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial. Issue 9 (September 2018)

2. CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia. (21st February 2018)

3. Early report on the severity of COVID‐19 in hematologic patients infected with the SARS‐CoV2 omicron variant. (16th July 2022)

6. Long‐term follow‐up and health‐related quality of life among cancer survivors with stage IEA orbital‐type lymphoma after external photon‐beam radiotherapy: Results from a longitudinal study. Issue 5 (7th August 2022)

7. Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia. (21st November 2018)

8. Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older. Issue 14 (6th December 2022)

9. Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors. Issue 12 (19th November 2019)

10. Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemia. Issue 12 (8th October 2021)